Provided by Tiger Trade Technology Pte. Ltd.

CSTONE PHARMA-B

10.100
-0.130-1.27%
Volume:5.68M
Turnover:57.25M
Market Cap:14.91B
PE:-27.89
High:10.320
Open:10.230
Low:9.880
Close:10.230
52wk High:13.150
52wk Low:2.300
Shares:1.48B
HK Float Shares:1.48B
Volume Ratio:0.29
T/O Rate:0.38%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.362
ROE:-89.13%
ROA:-18.89%
PB:21.01
PE(LYR):-27.89
PS:48.06

Loading ...

Stock Track | CStone Pharma-B Soars 5.05% Intraday on HK$1.05 Billion Placement to Fund Pipeline Development

Stock Track
·
Apr 16

CStone Pharmaceuticals-B Sees Over 4% Surge Following Proposed Placement to Raise HK$1.05 Billion

Stock News
·
Apr 16

CSTONE PHARMA-B Announces Placement of 118 Million Shares to Raise Approximately HK$1.053 Billion

Stock News
·
Apr 15

CStone Pharma to Raise HK$1.06 Billion via 118 Million-Share Placement at 6.95% Discount

Bulletin Express
·
Apr 15

CStone Pharmaceuticals - to Place Aggregate of 118 Mln Shares at HK$8.97 per Placing Share

THOMSON REUTERS
·
Apr 15

CStone Pharmaceuticals places 118,000,000 new shares at HK$8.97 each

Reuters
·
Apr 15

Evaluating CStone Pharmaceuticals (SEHK:2616) After ESMO Category I A Backing For Sugemalimab

Simply Wall St.
·
Apr 12

Stock Track | CSTONE PHARMA-B Soars 6.73% Intraday on Positive CS2009 Trial Data and Analyst Upgrade

Stock Track
·
Apr 10

CSTONE PHARMA-B Shares Surge Over 6% in Afternoon Trading on Analyst Upgrade

Stock News
·
Apr 10

CStone Pharma Reports Marginal Share Capital Movement in March; Issues 3,349 New Shares via Option Exercise

Bulletin Express
·
Apr 09

CStone Pharmaceuticals shifts to fully electronic distribution of corporate communications effective 2 April 2026

Bulletin Express
·
Apr 02

Adlai Nortye names Archie Tse president as Kaiyang Tang retires

Reuters
·
Apr 02

Gushengtang appoints Boyu Capital partner Cao Yanling as non-executive director

Reuters
·
Apr 01

A Look At CStone Pharmaceuticals (SEHK:2616) Valuation After Encouraging CS2009 Trial Results And Wider Losses

Simply Wall St.
·
Mar 31

Stock Track | CStone Pharma-B Soars 5.04% Intraday on Bullish Analyst Reports and Positive CS2009 Clinical Data

Stock Track
·
Mar 30

Two Major Foreign Institutions Bullish on CStone Pharma: Peak Target Price Set at HK$20, CS2009 Emerges as Key Catalyst

Stock News
·
Mar 30

CStone Pharmaceuticals' Loss Widens in 2025

MT Newswires Live
·
Mar 27

CStone Pharmaceuticals-B Surges Over 20% by Late Morning on Strong CS2009 Lung Cancer Efficacy Data

Deep News
·
Mar 27

CSTONE PHARMA-B (02616) Surges Over 20% on Strong CS2009 Lung Cancer Efficacy Data; First Phase III Global Trials Expected This Year

Stock News
·
Mar 27

Stock Track | CStone Pharma Soars 5.51% Intraday on Strong 2025 Results and Promising Pipeline Progress

Stock Track
·
Mar 27